Breast cancer is one of the most common cancers seen today. About 1 in 8 women in the US will develop invasive breast cancer over the course of their lifetime, and in 2022, an estimated 287,500 new cases of breast cancer are expected to be diagnosed in women in the United States, while more than 43,000 are expected to die from the disease.
While relatively common, the overall death rate from breast cancer has decreased steadily in recent years. This decrease is largely attributed to the results of advancements in treatments and earlier detection through screening.
As with all cancers, early detection through screening is vital. Frequent screening can catch
cancers earlier, and early-stage cancers are easier to treat and have a higher chance of survival than late-stage cancer.
Mammograms are the most common screening test for breast cancer, though an MRI may beused to screen women who have a high risk. A new type of test, however, is making it easy to test yourself for presence of the BRCA mutations at home.